Linda is Barclay Damon’s health care controversies team leader. A nationally recognized litigator with over 20 years of experience, she serves as lead litigation counsel as well as national, regional, and local counsel in the prosecution and defense of claims brought in state and federal courts on behalf of large groups of business and institutional clients.
Linda is a trusted advisor to health care providers, pharmaceutical companies, and pharmacies nationwide in resolving high-stakes disputes and government investigations. She represents health care professionals and entities in administrative proceedings, hearings, and appeals before various federal and state regulatory agencies, including the NYS Office of the Medicaid Inspector General (OMIG), the NYS Department of Health, and the NYS Workers’ Compensation Board. She also represents insurers, health-related providers, third-party administrators, and other regulated entities in investigative and regulatory proceedings.
Linda’s practice additionally focuses on complex multi-party litigation. She has extensive experience serving as regional, national, and trial counsel, representing drug manufacturers, product manufacturers, and contractors in the defense of class-certification applications and mass-tort claims. She has successfully litigated and managed thousands of asbestos cases for Garlock and other national and regional manufacturers. These engagements have included extensive trial work, leading to four verdicts in Upstate NY asbestos litigation as well as the successful management and coordination of discovery and national trial strategies.
In additional to her role at Barclay Damon, Linda has served as court-appointed defense liaison counsel for three jurisdictions in the Northern District of New York for the past 15 years. In this position, she has represented over 130 law firms practicing Upstate NY asbestos litigation.